What's Hot

When Will Taylor Swift Re-Release Her Debut Album? She Picked the Wrong Time.

October 24, 2026

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

October 24, 2026

My Son’s Baseball Season Came With a Lot of Extra Costs

October 24, 2026

Facebook X (Twitter) Instagram

Home
News
Politics
Money
Personal Finance
Business
Economy
Investing
Markets
Technology

Facebook X (Twitter) Instagram

Home»News»Takeda Pharmaceutical GAAP EPS of ¥94.00, revenue of ¥3212.9B; reaffirms FY23 guidance

News

Takeda Pharmaceutical GAAP EPS of ¥94.00, revenue of ¥3212.9B; reaffirms FY23 guidance

By Press RoomFebruary 1, 2024No Comments1 Min Read

Facebook Twitter Pinterest LinkedIn Tumblr Email

Share

Facebook Twitter LinkedIn Pinterest Email

Takeda Pharmaceutical GAAP EPS of ¥94.00, revenue of ¥3212.9B; reaffirms FY23 guidance

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

October 24, 2026

SA Asks: How can General Motors get back on track?

October 24, 2026

Berkshire Hathaway, Blackstone in gainers; HSBC, Globe Life among losers: week’s financials wrap

October 24, 2026

Leave A Reply Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Δ

LATEST NEWS

When Will Taylor Swift Re-Release Her Debut Album? She Picked the Wrong Time.

October 24, 2026

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

October 24, 2026

My Son’s Baseball Season Came With a Lot of Extra Costs

October 24, 2026

AI Data Centers Have a Ghost Problem

October 24, 2026

POPULAR

Business

The Business of Formula One

May 27, 2023

Business

Weddings and divorce: the scourge of investment returns

May 27, 2023

Business

How F1 found a secret fuel to accelerate media rights growth

May 27, 2023

Advertisement

Archives

Categories

Business
Crypto
Economy
Forex
Futures & Commodities
Investing
Market Data
Money
News
Personal Finance
Politics
Stocks
Technology

Your source for the serious news. This demo is crafted specifically to exhibit the use of the theme as a news site. Visit our main page for more demos.

We're social. Connect with us:

Facebook X (Twitter) Instagram Pinterest YouTube

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

Agree to the our terms and policy agreement.

Facebook X (Twitter) Instagram Pinterest

Home
Buy Now

© 2026 ThemeSphere. Designed by ThemeSphere.

Type above and press Enter to search. Press Esc to cancel.